Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.60 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.55 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.55 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.54 |
| ▸ | IDO1 | P14902 | 2/20 | 0.51 |
| ▸ | HTR2A | P28223 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | HTR2C | P28335 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1155658 | 1.00 | ADRA1A (0.60) | ADRA1ATAAR1MTNR1AMTNR1BAOC3 | |
| SCHEMBL23203396 | 1.00 | ADRA1A (0.60) | ADRA1ATAAR1MTNR1AMTNR1BAOC3 | |
| SCHEMBL9551466 | 1.00 | ADRA1A (0.60) | ADRA1ATAAR1MTNR1AMTNR1BAOC3 | |
| SCHEMBL25308876 | 0.86 | ADRA1A (0.68) | ADRA1ATAAR1MTNR1AMTNR1BAOC3 | |
| SCHEMBL10767997 | 0.85 | ADRA1A (0.62) | ADRA1ATAAR1MTNR1AMTNR1BAOC3 | |
| SCHEMBL5133668 | 0.85 | ADRA1A (0.62) | ADRA1ATAAR1MTNR1AMTNR1BAOC3 | |
| SCHEMBL8160809 | 0.85 | APLNR (0.54) | ADRA1ATAAR1HTR2AHTR2CCA12 | |
| SCHEMBL5932087 | 0.85 | GABRA1 (0.41) | ADRA1ATAAR1MTNR1AMTNR1BHTR2A | |
| SCHEMBL10601156 | 0.85 | ADRA1A (0.62) | ADRA1ATAAR1MTNR1AMTNR1BAOC3 | |
| SCHEMBL581510 | 0.83 | ADRA1A (0.60) | ADRA1ATAAR1MTNR1AMTNR1BAOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030129591-A1 | Linker arms for nanocrystals and compounds thereof | ROSENTHALL SANDRA J (US) | 2003-07-10 | — | — | US | disclosed |
| WO-2001090717-A2 | LINKER ARMS FOR NANOCRYSTALS AND COMPOUNDS THEREOF | VANDERBILT UNIVERSITY (US) | 2001-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030129591-A1 | Linker arms for nanocrystals and compounds thereof | SCO2, CTH, CYCS | ADRA1A 4462/4885TAAR1 3997/4885MTNR1A 2824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.